Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
The success of trials that have shown net clinical benefits of antithrombotic drugs as well as
the increasing prevalence of cardiovascular diseases in an ageing population have led to …
the increasing prevalence of cardiovascular diseases in an ageing population have led to …
Anticoagulation: low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and …
EA Nutescu, SA Spinier… - Annals of …, 2009 - journals.sagepub.com
Objective To develop practical recommendations for the use of low-molecular-weight
heparins (LMWHs) as prophylaxis and treatment of venous thromboembolism and acute …
heparins (LMWHs) as prophylaxis and treatment of venous thromboembolism and acute …
Cancer-associated venous thromboembolic disease, version 2.2021, NCCN clinical practice guidelines in oncology
MB Streiff, B Holmstrom, D Angelini, A Ashrani… - Journal of the National …, 2021 - jnccn.org
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cancer-Associated
Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of …
Venous Thromboembolic Disease focus on the prevention, diagnosis, and treatment of …
Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial
RD Hull, SM Schellong, VF Tapson… - Annals of internal …, 2010 - acpjournals.org
Background: Extended-duration low-molecular-weight heparin has been shown to prevent
venous thromboembolism (VTE) in high-risk surgical patients. Objective: To evaluate the …
venous thromboembolism (VTE) in high-risk surgical patients. Objective: To evaluate the …
Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians
A Qaseem, R Chou, LL Humphrey… - Annals of internal …, 2011 - acpjournals.org
Description: The American College of Physicians (ACP) developed this guideline to present
the evidence and provide clinical recommendations on prophylaxis of venous …
the evidence and provide clinical recommendations on prophylaxis of venous …
Cancer-associated venous thromboembolic disease, version 1.2015
MB Streiff, B Holmstrom, A Ashrani… - Journal of the National …, 2015 - jnccn.org
The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline
strategies for treatment and prevention of venous thromboembolism (VTE) in adult patients …
strategies for treatment and prevention of venous thromboembolism (VTE) in adult patients …
Anti-cancer properties of low-molecular-weight heparin: preclinical evidence
SA Mousa, LJ Petersen - Thrombosis and haemostasis, 2009 - thieme-connect.com
Malignant conditions are frequently associated with a hypercoaguable state, with recurrent
thrombosis due to the impact of cancer cells and chemotherapy or radiotherapy on the …
thrombosis due to the impact of cancer cells and chemotherapy or radiotherapy on the …
[HTML][HTML] The anti-factor Xa range for low molecular weight heparin thromboprophylaxis
MY Wei, SM Ward - Hematology reports, 2015 - pmc.ncbi.nlm.nih.gov
Low molecular weight heparins (LMWHs) are now the mainstay option in the prevention and
treatment of venous thromboembolism. In some patients receiving therapeutic doses of …
treatment of venous thromboembolism. In some patients receiving therapeutic doses of …
Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical …
FA Lederle, D Zylla, R MacDonald… - Annals of internal …, 2011 - acpjournals.org
Background: Venous thromboembolism prophylaxis has been recommended for
nonsurgical patients, but its effectiveness remains uncertain. Purpose: To assess the …
nonsurgical patients, but its effectiveness remains uncertain. Purpose: To assess the …
Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery
AT Rocha, ÂG de Vasconcellos, ER da Luz Neto… - Obesity Surgery, 2006 - Springer
Background: Obesity is considered a highly prevalent risk factor for venous
thromboembolism (VTE) in hospitalized patients. However, recommendations for VTE …
thromboembolism (VTE) in hospitalized patients. However, recommendations for VTE …